Y.S. Babu

6.4k total citations · 3 hit papers
97 papers, 5.3k citations indexed

About

Y.S. Babu is a scholar working on Molecular Biology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Y.S. Babu has authored 97 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 31 papers in Epidemiology and 21 papers in Organic Chemistry. Recurrent topics in Y.S. Babu's work include Biochemical and Molecular Research (23 papers), Influenza Virus Research Studies (22 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers). Y.S. Babu is often cited by papers focused on Biochemical and Molecular Research (23 papers), Influenza Virus Research Studies (22 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers). Y.S. Babu collaborates with scholars based in United States, United Kingdom and Australia. Y.S. Babu's co-authors include Charles E. Bugg, William J. Cook, Trevor J. Greenhough, Shanta Bantia, John S. Sack, Anthony R. Means, Pravin L. Kotian, John A. Montgomery, Pooran Chand and Yahya El-Kattan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Y.S. Babu

96 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of calmodulin refined at 2.2 Å resolution

1988 885 citations Y.S. Babu, Charles E. Bugg et al. Journal of Molecular Biology profile →
Three-dimensional structure of calmodulin

1985 853 citations Y.S. Babu, Trevor J. Greenhough et al. profile →
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

2014 461 citations Shanta Bantia, Pravin L. Kotian et al. profile →

Peers

Countries citing papers authored by Y.S. Babu

Since Specialization

Citations

This map shows the geographic impact of Y.S. Babu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y.S. Babu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y.S. Babu more than expected).

Fields of papers citing papers by Y.S. Babu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y.S. Babu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y.S. Babu. The network helps show where Y.S. Babu may publish in the future.

Co-authorship network of co-authors of Y.S. Babu

This figure shows the co-authorship network connecting the top 25 collaborators of Y.S. Babu. A scholar is included among the top collaborators of Y.S. Babu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y.S. Babu. Y.S. Babu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Scaffold hopping via ring opening enables identification of acyclic compounds as new complement Factor D inhibitors 2022 ·Bioorganic & Medicinal Chemistry ·Weihe Zhang, (unknown), (unknown), (unknown), Xiaogang Cheng, (unknown), (unknown), Lakshminarayana Vogeti, (unknown), Jason H. Williams, Kevin J. Polach, Xilin Chen, (unknown), Y.S. Babu, Pravin L. Kotian	4
2	Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE) 2021 ·Journal of Medicinal Chemistry ·Pravin L. Kotian, (unknown), (unknown), (unknown), Pengcheng Lu, (unknown), (unknown), Xilin Chen, (unknown), (unknown), Cynthia Parker, Jason H. Williams, Kevin J. Polach, Weihe Zhang, (unknown), Y.S. Babu	22
3	Long-acting potential of suprachoroidally delivered BCX4161, a selective plasma kallikrein inhibitor, for diabetic macular edema 2021 ·Investigative Ophthalmology & Visual Science ·(unknown), Yahya El-Kattan, Viral Kansara, Y.S. Babu, Thomas A. Ciulla	5
4	A direct-acting antiviral drug abrogates viremia in Zika virus–infected rhesus macaques 2020 ·Science Translational Medicine ·So‐Yon Lim, Christa E. Osuna, Katharine Best, Ray Taylor, (unknown), (unknown), (unknown), (unknown), Nancy Schultz‐Darken, Saverio Capuano, David Safronetz, Ma Luo, (unknown), Amanda Mathis, Y.S. Babu, William Sheridan, Alan S. Perelson, James B. Whitney	20
5	Intracellular rebinding of transition-state analogues provides extended in vivo inhibition lifetimes on human purine nucleoside phosphorylase 2017 ·Journal of Biological Chemistry ·(unknown), Scott A. Cameron, Lei Li, Y.S. Babu, Vern L. Schramm	19
6	Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model 2016 ·Antiviral Research ·Justin G. Julander, Venkatraman Siddharthan, J. T. Evans, Ray Taylor, (unknown), (unknown), (unknown), (unknown), Makda S. Gebre, (unknown), Arnaud J. Van Wettere, Young-Min Lee, William Sheridan, John D. Morrey, Y.S. Babu	127
7	A Simple, Sensitive and Selective Fluorogenic Assay To Monitor Plasma Kallikrein Inhibitory Activity Of BCX4161 In Activated Plasma 2014 ·Journal of Allergy and Clinical Immunology ·Y.S. Babu, (unknown), Jianwen Zhang, Melanie Cornpropst, Phil Collis, William Sheridan	4
8	Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme 2011 ·Antiviral Research ·Shanta Bantia, Ramanda Upshaw, Y.S. Babu	14
9	Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model 2010 ·Antiviral Research ·Shanta Bantia, (unknown), Cynthia Parker, Y.S. Babu	26
10	Design, parallel synthesis, and crystal structures of biphenyl antithrombotics as selective inhibitors of tissue factor FVIIa complex. Part 1: Exploration of S2 pocket pharmacophores 2009 ·Bioorganic & Medicinal Chemistry ·Pravin L. Kotian, (unknown), (unknown), Yahya El-Kattan, Surendra Kumar Saini, Ramanda Upshaw, Shanta Bantia, (unknown), Y.S. Babu, Pooran Chand	10
11	Synthesis of a potent 5′-methylthioadenosine/S-adenosylhomocysteine (MTAN) inhibitor 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Philip E. Morris, Y.S. Babu	7
12	Extractive preconcentration of cobalt, nickel and manganese with 5,7-diiodo-8-hydroxyquinoline and determination by flame AAS 2004 ·Chemia Analityczna ·(unknown), T. Balaji, T. Prasada Rao, (unknown), Y.S. Babu, G. R. K. Naidu	4
13	Hydrophobic benzoic acids as inhibitors of influenza neuraminidase 1999 ·Bioorganic & Medicinal Chemistry ·Venkatram R. Atigadda, Wayne J. Brouillette, (unknown), Y.S. Babu, Shanta Bantia, Pooran Chand, (unknown), John A. Montgomery, David A. Walsh, E. Sudbeck, (unknown), Gillian M. Air, Ming Luo, Graeme Laver	26
14	Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping 1999 ·Bioorganic & Medicinal Chemistry Letters ·Wayne J. Brouillette, Venkatram R. Atigadda, Ming Luo, Gillian M. Air, Y.S. Babu, Shanta Bantia	23
15	Structure of 3,4-Dichloroisocoumarin-Inhibited Factor D 1998 ·Acta Crystallographica Section D Biological Crystallography ·L. Brent Cole, J. Michael Kilpatrick, (unknown), Y.S. Babu	21
16	Guanidinobenzoic acid inhibitors of influenza virus neuraminidase 1 1Edited by R. Huber 1997 ·Journal of Molecular Biology ·E. Sudbeck, M.J. Jedrzejas, Sangeeta Singh, Wayne J. Brouillette, Gillian M. Air, W.G. Laver, Y.S. Babu, Shanta Bantia, Pooran Chand, (unknown), John A. Montgomery, David A. Walsh, Ming Luo	31
17	Calculation of relative binding affinities of purine nucleoside phosphorylase inhibitors 1995 ·Acta Crystallographica Section D Biological Crystallography ·Michael A. Carson, (unknown), Y.S. Babu, Jane Montgomery	3
18	Crystallization and preliminary X-ray investigation of a sarcoplasmic calcium-binding protein from amphioxus 1991 ·Journal of Molecular Biology ·W. James Cook, Y.S. Babu, Jos A. Cox	2
19	Crystallization and preliminary X-ray investigation of factor D of human complement 1991 ·Journal of Molecular Biology ·Sthanam V.L. Narayana, J. Michael Kilpatrick, Ossama El‐Kabbani, Y.S. Babu, Charles E. Bugg, John E. Volanakis, (unknown)	4
20	Rotation function studies of human C-reactive protein 1990 ·Journal of Molecular Biology ·Dean A. A. Myles, (unknown), L.J. DeLucas, Y.S. Babu, (unknown), John E. Volanakis, Charles E. Bugg, S. Bailey, Trevor J. Greenhough	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact